Opportunity
Problem
Psilocybin is listed as a Schedule I substance under the Controlled Substances Act, which means that it is considered to have a high potential for abuse and has no currently accepted medical use. This classification also makes it illegal to possess, distribute, or use psilocybin in the United States without proper authorization or exemption.
There has been a growing movement to re-examine the therapeutic potential of psilocybin and other psychedelic substances, and some research studies have been conducted to investigate their use for various medical and psychological conditions. Some clinical trials have shown promising results in using psilocybin-assisted psychotherapy for depression, anxiety, addiction, and end-of-life distress in patients with terminal illnesses.
Psilocybin is a naturally occurring compound found in certain species of mushrooms, and it has been used for spiritual and medicinal purposes by indigenous cultures for centuries. In recent years, there has been a growing interest in using psilocybin as a holistic medicine for various physical, mental, and emotional conditions.
Some people use psilocybin as a holistic medicine for conditions such as depression, anxiety, addiction, and PTSD. There is some preliminary evidence from small studies suggesting that psilocybin-assisted psychotherapy may be effective in treating these conditions. However, more research is needed to fully understand the potential benefits and risks of psilocybin as a holistic medicine.
It’s important to note that psilocybin is a powerful psychoactive substance that can have profound effects on perception, cognition, and emotion. It should only be used under the guidance of a qualified healthcare professional, in a safe and controlled environment. Additionally, psilocybin is illegal under federal law in the US, and its use carries legal risks.
There are several problems associated with using psilocybin in the US, both from a legal and medical perspective.
From a medical perspective, psilocybin is a powerful psychoactive substance that can have both positive and negative effects on the mind and body. While some research studies have suggested that psilocybin may be effective in treating certain mental health conditions, such as depression and anxiety, more research is needed to fully understand its safety and effectiveness.
There are also potential risks associated with psilocybin use, such as hallucinations, paranoia, and confusion. These risks can be minimized by using psilocybin under the supervision of a qualified healthcare professional in a safe and controlled environment.
Additionally, psilocybin can have interactions with other medications or medical conditions, which can pose a risk to the user’s health. It’s important for anyone considering using psilocybin as a medicine to consult with a healthcare professional and disclose any medical conditions or medications they are taking.
Fig 1: Psilocybin results in the US: Finally Detached
Solution
Any solution to using psilocybin as a holistic medicine in the US should prioritize the safety and well-being of patients and be based on rigorous scientific evidence.
The use of psilocybin as a holistic medicine in the US is a complex issue that requires a multi-faceted solution. Here are a few potential steps that could be taken:
- Conduct more research: There is a need for more research into the safety and efficacy of psilocybin as a medicine. Conducting well-designed clinical trials can help to determine the potential benefits and risks of psilocybin, as well as identify which conditions it may be most effective in treating.
- Reclassify psilocybin: Psilocybin’s Schedule I classification makes it difficult to conduct research and access the substance for therapeutic purposes. Reclassifying psilocybin to a lower schedule or removing it from the controlled substances list altogether could help to facilitate its use as a medicine.
- Create exemptions for medical use: The federal government could create exemptions for the medical use of psilocybin, allowing for its use in a controlled and regulated manner for certain conditions.
- Provide education and training: Healthcare professionals should receive training on the use of psilocybin as a medicine and how to manage the potential risks and side effects. Patients should also receive education on the risks and benefits of psilocybin before deciding to use it.
- Decriminalize or legalize psilocybin: Several cities and states in the US have already decriminalized or legalized psilocybin for medical or therapeutic purposes. Expanding these efforts to a national level could help to facilitate its use as a medicine and reduce legal risks.
Market
Psilocybin, a naturally occurring psychedelic compound found in certain mushrooms, has gained increasing attention for its potential to treat various mental health conditions, including depression, anxiety, and addiction.
Currently, Psilocybin is not approved as a medicine by the US Food and Drug Administration (FDA). However, there is growing interest in the potential therapeutic benefits of psilocybin, and clinical research is underway to investigate its use for conditions such as depression, anxiety, and addiction.
In recent years, there has been a growing movement towards the decriminalization and legalization of psilocybin for medical and therapeutic use. Several cities and states in the US have decriminalized psilocybin or are in the process of doing so, and some companies are exploring the development of psilocybin-based medicines.
Oregon has recently passed a ballot measure that decriminalizes the possession and personal use of small amounts of psilocybin mushrooms, as well as other drugs, and allows for the licensed administration of psilocybin-assisted therapy in certain circumstances.
Under the Oregon Psilocybin Services Act (Measure 109), licensed facilitators will be able to provide psilocybin-assisted therapy to individuals over the age of 21 who have received a diagnosis of a qualifying mental health condition. The law sets up a regulatory framework for the administration of psilocybin therapy, including training requirements for facilitators and limits on the amount of psilocybin that can be administered.
Currently, there are no regulations in Jamaica prohibiting the use of psilocybin. Jamaica’s government has never outlawed the hallucinogenic fungus and is now cultivating investors to build up its psychedelics industry, which according to one estimate, could be worth $8 billion globally by 2028.
As more research is conducted and regulatory barriers are addressed, the possibility exists that the market for psilocybin as a holistic medicine in the US could continue to grow. It is important to note that any use of psilocybin for medical or therapeutic purposes should be done under the guidance of a qualified healthcare professional in a controlled and safe environment.
Jamaica now has at least four psilocybin-focused resorts, three of which opened recently as the government has warmed to psychedelics and encouraged private investment in the sector.
To get more locals involved in the industry, Jamaica Promotions Corporation (Jampro) has identified opportunities in cultivation, development of facilities that can process the fungus according to international standards, development of treatment facilities, and research and development.
Jampro intends to position Jamaica as a primary destination for research and development, particularly in using the mushroom for developing treatments and the potential for export.
By researching the market thoroughly, we can minimize the risk to our business; identify new opportunities, while helping us to communicate better with our patients.
We identify our market’s key demographic, geographic, psychographic, and behavioristic characteristics, as follows:-.
- Demographic: Age, Gender, Income, Education, Ethnicity, Family size.
- Geographic: Region, city, neighborhood.
- Psychographic: Social class, lifestyle, personality, values, life stage.
- Behavioristic: Loyalty, and attitude.
Fig 2: Global Psychedelic Drugs market 2021 – 2025: Finally Detached.
Roadmap
Our roadmap will ensure we take a good look at all aspects of the business requirements. This will result in a strategic tool that will serve as a guide for better and more effective management. It will help us to identify opportunities and challenges and will also focus our attention on important questions to be tackled.
By following this roadmap, Finally Detached can create a safe and effective retreat experience for participants who are interested in exploring the potential benefits of psilocybin and other psychoactive substances.
The roadmap for our business expansion is focused on developing a clear vision and strategy, establishing financial controls, identifying and prioritizing target markets, expanding our team as needed, continuously improving our products and services, investing in technology and infrastructure, and staying up-to-date with industry trends. By following this roadmap, Finally Detached can position our business for long-term success and growth.
We are currently planning to leverage our agility, flexibility, and expertise to expand our team as needed. As such, the roadmap for our business expansion can be summarized as follows:
- Identify and prioritize target markets and patient segments.
- Develop and refine our brand identity, marketing messaging, and communication strategy to effectively reach and engage with our target audience.
- Expand our team as needed to support our growth and improve our operational efficiency.
- Continuously improve our products and services to meet the evolving needs of our patients.
- Invest in technology and infrastructure to support our expansion and improve our ability to scale.
- Establish and maintain strong relationships with suppliers, partners, and other stakeholders.
- Stay up-to-date with industry trends and emerging technologies to remain competitive and innovative.
- Regularly review and evaluate our progress against our goals and adjust our strategy as needed to stay on track.
Our Roadmap to success will be:
Finally Detached can position the business for long-term success by focusing on continuous improvement and creating a safe and effective retreat experience for patients who are interested in exploring the potential benefits of psilocybin and other psychoactive substances.
- Develop a Clear Vision and Mission: Finally Detached will start by developing a clear vision and mission for our retreat. Define our goals and objectives and create a mission statement that reflects our values and purpose.
- Legal Considerations: Ensuring that Finally Detached is complying with all applicable laws and regulations related to the use of psilocybin or other psychoactive substances in our location.
- Safety Measures: Finally Detached will develop a comprehensive safety plan that includes measures to ensure the physical and emotional safety of patients. This will include screening patients for medical conditions and other factors that may increase the risk of adverse reactions, establishing appropriate dosages, and providing medical personnel on-site in case of emergencies.
- Experienced Staff: Finally Detached will hire staff members who are experienced and trained in working with psychoactive substances. They need to be knowledgeable about the effects and potential risks of psilocybin, as well as experienced in providing support to individuals who may have challenging experiences during the retreat.
- Course Curriculum: Finally Detached will develop a well-planned course curriculum that includes educational material on the effects of psilocybin, methods for managing challenging experiences, and ways to integrate the insights gained during the retreat into daily life. This curriculum will be designed to support patients in achieving their individual goals for the retreat.
- Post-Retreat Support: Finally Detached has a plan in place for providing post-retreat support to patients. This will include follow-up sessions with facilitators, peer support groups, and referrals to therapists or other professionals if necessary.
- Marketing and Branding: Finally Detached will develop a strong brand identity and marketing strategy to effectively reach and engage with potential patients who may benefit from the retreat.
- Partnerships and Collaborations: Finally Detached will establish relationships with reputable suppliers and partners who can provide support and resources for the retreat.
- Continuous Improvement: Finally Detached will regularly review and evaluate the retreat program and curriculum to ensure that it is effective and aligned with the needs of patients.
Revenue Milestones:
1-year milestone is to surpass $500,000 in revenue
3-year milestone is to surpass $5,000,000 in revenue
5-year milestone is to surpass $10,000,000 and position for sell-off.
Products/ Services Milestones:
– Take-home therapy kit
– Pre-ceremony reprogram course package
– Integration rewiring course package
– Spores and microdoses
– Full comprehensive retreat – cleanse, experience, and learn how to cultivate
– Medicinal mushroom blends
Geographic Milestones:
Oregon: Finally Detached plans to establish a location in Oregon this year and make it the permanent home for our business. This location will serve as a base of operations for our business, allowing the business to offer our services to patients in the local area.
Jamaica: Finally Detached plans to either partner with a legitimate retreat center in Jamaica or purchase a property to start offering our complete services and packages. This location is chosen for its branding and positioning purposes, as Jamaica is a well-known destination for wellness and spiritual retreats.
Biggest Milestone:
The biggest milestone for Finally Detached is to cut out all middlemen and have a compound where all services can be done in-house. This would allow our business to have greater control over the entire process, from cultivation to retreats and education. Additionally, our company plans to use its current services and cash flow to make real estate plays in areas of the world where this is legal, and to use these locations for retreats, cultivating education, and more.
This milestone has the potential to greatly benefit our business in several ways. By having control over the entire process, our business can ensure a higher level of quality and consistency in its services. Additionally, owning and operating our compounds can provide long-term stability and revenue streams for our business, while also potentially opening up new opportunities for expansion and growth.
Overall, this milestone represents a significant step forward for our retreat business using Psilocybin and cannabis, allowing our company to have greater control and stability in its operations while potentially opening up new opportunities for growth and expansion.
Company Overview
Finally Detached was started right after the Covid pandemic to test the potential benefits of using psychedelics for mental health, which had gained increasing popularity. To do this legally, the founder, Gabriel Castillo created a church. Some organizations have used religious protections to legally use certain psychedelics in their rituals.
Finally Detached saw an opportunity to use this approach to explore the potential benefits of psychedelics for mental health while staying within the bounds of the law. The initial success of the concept led to the development of a specific way to work with magic mushrooms that guarantee success.
To comply with legal requirements, an LLC was set up and a church setting was adopted. The founder has now opened an LLC in Oregon to expand the business operations and build everything legitimately and “above board”. Gabriel Castillo is motivated and dedicated to the mission of Finally Detached, describing it as his soul’s purpose. With a warrior mentality, he is committed to executing the plan and taking the business to the next level.
Finally Detached is a young company with a unique approach to exploring the benefits of psychedelics for mental health.
